Tyra Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $79,945,000.
Profit Margin
| 2019 | 0 | -4.05M | |
|---|---|---|---|
| 2020 | 0 | -9.31M | |
| 2021 | 0 | -26.14M | |
| 2022 | 0 | -51.72M | |
| 2023 | 0 | -69.13M |
TYRA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 353K | 296K | 140K | 47K | 8K |
Gross profit | -353K | -296K | -140K | -47K | -8K |
Operating exp. | |||||
Research and development | 62.51M | 43.00M | 20.63M | 7.20M | 1.79M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 79.94M | 58.92M | 26.28M | 9.29M | 3.12M |
Operating income | -79.94M | -58.92M | -26.28M | -9.29M | -3.12M |
Other income (expenses), net | 10.81M | 3.60M | -6K | -39K | -943K |
Income before tax | -69.13M | -55.32M | -26.29M | -9.33M | -4.06M |
Income tax expense | 0 | -3.60M | -153K | -22K | -7K |
Net income | -69.13M | -51.72M | -26.14M | -9.31M | -4.05M |
Earnings per share | |||||
Basic EPS | -1.62 | -1.23 | -0.63 | -0.22 | -0.09 |
Diluted EPS | -1.62 | -1.23 | -0.63 | -0.22 | -0.09 |
| Data source | Data source | Data source |